ResearchSafe

Feedback on a 12‑week KLOW‑plus‑tirzepatide stack for tendon rehab and weight loss

Posted by trevor_recovery in Protocols & Stacks - 1 points, 0 comments.

I’ve been running a combined protocol for the last 8 weeks and want some eyes on the details before I push to week 12. My aim is to keep my Achilles tendon healing while also losing body fat for a beach competition.

I reconstitute BPC‑157 to 2 mg/ml (0.5 ml bacteriostatic water into a 1 ml vial) and inject 250 µg subcutaneously each morning. TB‑500 I keep at 5 mg/ml (2 ml bacteriostatic water into a 2 ml vial) and give 2 mg twice a week, spaced 48 h apart. GHK‑Cu I mix 200 µg in 0.5 ml sterile water and do 200 µg subcutaneously three times a week, on non‑TB‑500 days. KPV I reconstitute to 1 mg/ml and take 500 µg daily, same injection site as BPC‑157.

For weight loss I added compounded tirzepatide, 5 mg weekly, injected on the same day as my first TB‑500 dose. I started at 2.5 mg for two weeks, titrated up to 5 mg after a mild nausea episode that resolved with a light breakfast.

So far I’ve seen less tendon soreness after sprint sessions, and the scale is down about 3 kg with no loss of strength. I sometimes feel a slight flushing after GHK‑Cu, but no injection site issues.

Anyone spot potential interactions, dosing timing tweaks, or safety concerns with this mix? Especially regarding tirzepatide and the peptide anti‑inflammatory load. Thanks!

Community discussion - research and educational context only. Not medical advice.